Seven-Day Peel-and-Place NPWT for Leg Wounds
Seven‑Day “Peel‑and‑Place” NPWT: Early Clinical Experience, Setup Tips, and Case Highlights
Medical education note: The content below is for clinicians. It is not a substitute for device IFUs, local protocol, or patient-specific medical advice.
Quick take (for the busy wound clinician)
A small initial series found that a novel encapsulated, peel-and-place NPWT dressing—built around a polyurethane foam manifolding core with a hybrid silicone–acrylic drape—maintained seals for up to seven days, was faster and easier to apply and remove than traditional reticulated open-cell foam (ROCF), and supported visible healing progression (granulation, epithelialization, and wound-size reduction) in six complex lower-extremity wounds from four patients (ages 23–69). Continuous −125 mmHg was used; dressings were changed at least weekly. Similar wear-time and ease-of-use claims (including ~2-minute application) and extended-wear design are described for the 3M™ V.A.C.® Peel and Place Dressing. (1,2)
Why consider a peel-and-place NPWT dressing?
Traditional ROCF is a workhorse for NPWT, but multiple guidelines note that foam is typically changed every 48–72 hours to reduce granulation tissue ingrowth into the foam, which can increase pain, bleeding, and wound-bed disruption on removal. (3,4)
A peel-and-place concept encapsulates the foam and pairs it with a hybrid silicone–acrylic drape designed for longer wear and gentler removal, aiming to extend wear time up to seven days while simplifying application—potentially reducing total dressing changes, chair time, and patient discomfort. Product and marketing data for V.A.C.® Peel and Place describe up to seven-day wear, significantly shorter average application time versus traditional foam, and reduced dressing-change frequency. (1,5)
What this initial experience reported
(49 year old male with right dorsal foot diabetic ulcer 2 weeks after blunt trauma occurred)
Population & wounds: Four patients (2 F / 2 M) with six complex lower-extremity wounds received the peel-and-place NPWT dressing, consistent with early case-based use of extended-wear NPWT dressings in complex leg and foot wounds. (1,6)
Technique: After excisional debridement as needed and systemic antibiotics when indicated, the peel-and-place NPWT dressing was applied with the foam core extending ≥ 1 cm beyond the wound perimeter, connected via multilumen tubing, and run at −125 mmHg continuous. The change interval was at least every 7 days—mirroring manufacturer guidance that Peel and Place can be worn up to seven days between changes. (1,2)
Ease of use: Clinicians in the series rated peel-and-place faster and easier to apply and remove than hand-cut ROCF. Simulated-use studies of V.A.C.® Peel and Place show a similar pattern: average application time ~1:48 versus ~4:40 for traditional foam plus drape (p<0.01). (1,5)
Patient experience: Patients preferred fewer dressing changes; Peel and Place product evaluations report reduced dressing-change frequency (up to 67% fewer changes per week) and painless or low-pain removal in small user preference tests. (5,7)
Clinical trajectory: All six wounds showed forward progression (granulation tissue formation, dimensional reduction, epithelialization) over the treatment window, which is consistent with preclinical and early clinical data suggesting that longer-wear NPWT dressings can maintain or improve granulation and epithelialization compared with standard foam under similar pressure settings. (6,8)
How to set it up (clinic playbook)
Always follow the device IFU. The outline below mirrors the poster’s protocol and published manufacturer instructions.
Debride first. Perform excisional debridement to remove devitalized tissue and manage infection with systemic antibiotics as needed; this is standard practice in NPWT guidelines and in clinical reports using extended-wear dressings. (3,8)
Sizing & placement. Remove release liners; position the peel-and-place dressing so the foam core extends ≥ 1 cm past wound edges to ensure uniform manifolding under the drape. Manufacturer guides for Peel and Place emphasize pre-sized encapsulated foam and simplified placement without cutting, while still ensuring coverage beyond wound margins. (1,2)
Seal & connect. Smooth the hybrid silicone–acrylic drape to achieve an airtight seal and connect multilumen tubing to the NPWT pump. Hybrid silicone–acrylic drapes used with NPWT have been shown in case series to maintain seals over anatomically challenging sites while allowing less traumatic removal. (9,10)
Pressure & mode. Initiate −125 mmHg continuous NPWT. This pressure and mode are widely used in NPWT practice and feature prominently in manufacturer protocols and clinical case reports for Peel and Place and related drape technologies. (1,6)
Wear time. Change the dressing at least every 7 days (earlier if clinically indicated by exudate, edge maceration, or leaks). The series reported no seal failures during the intended wear interval, and product literature positions Peel and Place as the first V.A.C.® Therapy dressing specifically indicated for up to seven days of wear. (1,2)
Practical pearls from the cases
Speed saves. Teams reported that encapsulation plus peel-away liners made application and removal faster than ROCF, trimming chair time and reducing the “foam art project” factor for irregular shapes. Simulated-use testing likewise found significantly shorter application times for Peel and Place versus traditional NPWT foam with a separate drape. (1,5)
Fewer touches. Once-weekly changes limit opportunities for wound-bed disturbance and patient discomfort from frequent foam exchanges. WoundReference and other product sources highlight reductions in weekly dressing-change frequency of ~60–70% when using Peel and Place instead of standard foam, which is directionally consistent with this series. (5,7)
Reliable seals. The hybrid drape maintained negative pressure throughout the intended wear period across all cases. Similar real-world reports of hybrid silicone–acrylic drapes used with NPWT describe durable seals over seven-day intervals with minimal leak events. (9,10)
Cost & workflow. The authors highlight potential reductions in cost and application time compared with ROCF, derived from extended wear and simplified handling. Commercial summaries for Peel and Place likewise claim reduced application time, fewer dressing changes per week, and streamlined training requirements, which can translate into lower staff time and logistical burden. (1,5)
When might this approach fit?
In this small series, peel-and-place NPWT was used on complex lower-extremity wounds after appropriate debridement and infection control—similar to early published cases in diabetic foot and other lower-extremity wounds where a Peel and Place dressing was worn intact for seven days with complete healing or marked improvement. (6,11)
If your patient and practice would benefit from fewer NPWT changes, shorter visits, or gentler dressing removal, a peel-and-place option may be worth trialing—provided indications and contraindications in the IFU are met (for example, manufacturer guidance for Peel and Place limits use in wounds deeper than 6 cm or with significant tunneling/undermining). (1,2)
Results
(49 y/o male with right diabetic foot ulcer closed after 11 weeks of treatment)
Patients: 4 (2 F / 2 M), ages 23–69
Wounds: 6 complex lower-extremity wounds
NPWT setting: −125 mmHg continuous
Wear interval: Change at least every 7 days
Sealing: Maintained seals for intended wear time (no reported leaks)
User experience: Easier and faster application/removal vs ROCF
Patient experience: Higher satisfaction due to fewer changes
Healing trajectory: Granulation, size reduction, and epithelialization in all wounds during therapy
All points above are consistent with early Peel and Place product evaluations and with porcine and human data showing that novel longer-duration NPWT dressings can safely support seven-day wear, maintain seals, and achieve robust granulation without problematic tissue ingrowth. (6,8)
Limitations (read before you extrapolate)
This is a small, uncontrolled initial series (4 patients / 6 wounds) with no head-to-head randomization against standard ROCF. Most published Peel and Place data so far are manufacturer-sponsored animal studies, simulated-use evaluations, product guides, and individual case reports, rather than large randomized clinical trials. (1,6)
The experience also comes from a single group; workflow and outcomes may reflect center-specific expertise and patient selection. As with much NPWT innovation, trademarked products and industry involvement should be considered when interpreting usability and performance claims. (8,9)
References
3M / Solventum. 3M™ V.A.C.® Peel and Place Dressing Kit – Product Guide. Indicates all-in-one encapsulated foam/drape design with up to 7-day wear time, simplified application, and reduced training time.
Link: https://multimedia.3m.com/mws/media/2401145O/3m-v-a-c-peel-and-place-dressing-kit-product-guide-en.pdfWoundSource. V.A.C.® Peel and Place Dressing Kit. Describes it as the first V.A.C.® Therapy dressing that can be worn for up to seven days, with average application time under 2 minutes.
Link: https://www.woundsource.com/product/vac-peel-and-place-dressing-kitMansoor J, et al. Clinical evaluation of improvised gauze-based negative pressure wound therapy. Indian J Plast Surg. 2013. Notes that traditional NPWT foam dressings are generally changed every 48–72 h.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7950495/Wound Care Guidelines – CLWK. Negative Pressure Wound Therapy – Reusable & Disposable Guideline. 2024. Recommends foam changes every 48–72 h to limit granulation ingrowth and associated pain on removal.
Link: https://www.clwk.ca/get-resource/negative-pressure-wound-therapy-reusable-disposable-guideline/WoundReference. 3M V.A.C. Peel and Place Dressing Kit, Small – Product Page. Summarizes claimed reductions in dressing-change frequency and application time, and increased re-epithelialization vs traditional foam in preclinical models.
Link: https://woundreference.com/p/product?id=3m-vac-peel-and-place-dressing-kit-small-case-of-5Allen D, et al. Preclinical assessment of novel longer-duration wear negative pressure wound therapy dressing in a porcine model. 2023. Demonstrates safe seven-day wear with reduced tissue ingrowth and improved granulation vs standard foam.
Link: https://pubmed.ncbi.nlm.nih.gov/37074154/Solventum / 3M. Solventum™ V.A.C.® Peel and Place Dressing – Product and performance summary. Includes simulated-use data on faster application and patient preference for painless removal.
Link: https://www.solventum.com/en-ca/home/f/b5005538007/Huang C, et al. The evolution of commercial negative pressure wound therapy systems for open-wound management. Adv Wound Care (New Rochelle). 2023. Reviews NPWT mechanisms and newer dressing technologies, including extended-wear and specialty drapes.
Link: https://www.liebertpub.com/doi/10.1089/wound.2023.0115Fernández LG, et al. Use of a novel silicone–acrylic drape with negative pressure wound therapy in anatomically challenging wounds: a 6-patient case series. Int Wound J. 2020. Shows durable seals and less traumatic removal using a hybrid silicone–acrylic drape at up to 7 days.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7754137/3M. 3M™ V.A.C. Dermatac™ Drape with 3M™ V.A.C. Therapy – Case Study Booklet. Demonstrates silicone–acrylic hybrid drape performance, including seven-day NPWT courses with good graft take and low pain on removal.
Link: https://multimedia.3m.com/mws/media/2238047O/3m-v-a-c-dermatac-drape-with-3m-v-a-c-therapy-case-studies-en-ca.pdfGreenstein D, et al. Use of V.A.C. Peel and Place Dressing for Diabetic Foot Wounds. Dialogues in Wound Management. 2024. Case report of a diabetic foot wound treated with Peel and Place: intact seal and painless removal after 7 days with complete healing.
Link: https://dialoguesinwoundmanagement.com/wp-content/uploads/2024/12/22022-CDWM-Greenstein-Peel-and-Place-Article-ENG-v3.pdf
